The progress made in defining the etiology of insulindependent diabetes mellitus (IDDM) has occurred in fits and starts. Before 1973, it was assumed that IDDM was partly genetic, based on the familial clustering of cases and the increased concordance in monozygotic versus dizygotic twins. In 1973, it was shown that certain HLA antigens were associated with the presence or absence of IDDM (1, 2) . Although many investigations have since been performed that further elaborated on the observed HLA-IDDM association, little significant progress was made until 1987 when DNA sequencing allowed specific amino acid residues of HLA class II genes to be correlated with IDDM susceptibility (3-6).
In a sense, the new molecular findings concerning IDDM can still be classified as "completing" our knowledge about the HLA-IDDM association, and it may be argued that we are actually no further along in defining the genetic architecture of IDDM susceptibility than we were in 1973. After all, IDDM susceptibility is only partly genetic (at most 50%, based on twin data), and of this genetic contribution, the HLA-associated genes have been thought to contribute only 50% to the liability (7). Even with the molecular characterization of IDDM with respect to HLA class II sequences, 5% of IDDM patients had a "resistant" gene, whereas 20% of individuals without IDDM had two doses of the "susceptible" genes (6). This leads to the conclusion that addi-tional genetic information needs to be incorporated into a full model of genetic susceptibility.
Whereas the genetics of IDDM have been widely publicized and intervention strategies based on immune regulation are planned, significant progress in the epidemiology of IDDM has been made, often with much less fanfare. The correlation of incidence and prevalence with HLA antigen distribution for a particular population, although informative, has not provided a significant increase in our knowledge of IDDM, in that the distribution of HLA antigens is naturally confounded with ethnicity. However, two epidemiological findings have led to more refined investigations concerning environmental triggers or protective agents of IDDM onset. The first finding reported the seasonality pattern of IDDM incidence, roughly correlating with occurrences of infectious disease (8). The second finding was the isolation of Coxsackie virus from a child with ketoacidosis (9). More recently, a geographic distribution pattern of IDDM has emerged from a multicenter international study that reports the increased risk of IDDM with increasing distance from the equator (10). A question that must be addressed is whether these correlations and associations can be tested for causation.
Studies of incidence and prevalence of IDDM have demonstrated a wide range of rates between different countries and within geographic areas within a country. A common complaint from many who do not "appreciate" epidemiology is that much of what has been described is observational and does not answer significant questions. Ethnic variation in rates, temporal trends, and geographic distributions of IDDM occurrence are important data, as are rates in mixed populations (e.g., the Mexican-American studies cited in this issue and in other studies; 11-14). However, how many studies of IDDM prevalence are needed? To be fair, how many studies of HLA associations in different populations are needed? From the perspective of novel insights into IDDM pathogenesis and the cost associated with epidemiological (and HLA antigen association) studies, a persuasive argument could be made that the need for studies of incidence and prevalence of IDDM is no longer a priority.
If additional studies of incidence and prevalence of IDDM are not needed, then what is needed? Again, although it is true that ethnic variation is indicative of genetic contributions to IDDM susceptibility, these ethnic differences are also consistent with environmental effects that either increase or reduce the underlying genetic liability for disease. Also, the maximum of 50% concordance rate for IDDM in monozygotic twins indicates that at least 50% of IDDM susceptibility results from environmental causes. For those interested in disease prevention, the environment can be much more easily manipulated than individual genes. Thus, there is an obvious need to construct models to identify risk factors and to create studies that can test hypotheses concerning these models in specific populations as they relate to genetic susceptibility.
The combined genetic and epidemiological approach will probably have greater power to resolve IDDM pathogenesis than either applied separately. There have been many reports of viral exposures before onset of clinical IDDM, but results concerning the importance of viral exposure as a risk factor have been equivocal. Recent studies of sequence homology between human viral pathogens and the susceptible HLA-DQ proteins have been undertaken (4). Thus, the E1 envelope protein of the rubella virus contains a sequence of five amino acid residues (Gly-Pro-Pro-Ala-Ala) that is identical to residues 54-58 of the HLA-DQ p-chain DQw3.2 allele, which is "susceptible" for IDDM. Similarly, the IE2 protein of the cytomegalovirus contains a sequence of six amino acid residues (Pro-Leu-Gly-Arg-Pro-Asp), which has five of six amino acid identity with residues 51-57 of the HLA-DQ p-chain DQw1.2 allele which is "resistant" (15). These examples of sequence homology illustrate the potential for a virus to "hide" from the immune process and to serve as an initiator of islet destruction. The further correlation of these and other candidate viral triggers (e.g., Coxsackie virus and encephalomyocarditis) with molecular markers of risk in highly characterized populations may resolve epitope mimicry and disease susceptibility.
Other issues of IDDM epidemiology are being addressed in numerous studies. A valuable outcome of any epidemiological study is information that allows further, more focused investigation. The "clues" collected concerning environmental agents (e.g., certain food additives as inducers, the protective effect of breast-feeding) need to be evaluated in a rigorous manner. The role of epitopic sensitization and differential susceptibility for IDDM in offspring of diabetic mothers versus offspring of diabetic fathers needs to be further evaluated (16). This threefold increase in risk to offspring of diabetic fathers is not predicted from models of genetic susceptibility, because the genetic contribution is thought to be autosomal in nature. Therefore, the resolution of these data may lie in the interactions of genes of the HLA region with other immune factors and/or interactions with exogenous environmental factors whose effect is greater in one sex.
The available information indicates that the increased risk for IDDM is a combination of genetic liability (partly from HLA class II genes) and exogenous environmental factors. The search for the other IDDM susceptibility genes and the environmental modifiers requires focused hypotheses, testable models, and an integrated approach. In the face of potential gene-environment interaction and genetic heterogeneity, the specification of individual risk for IDDM may not be possible, because time of exposure to an environmental agent may determine whether HLA-identical siblings are concordant or discordant for disease. Because the diabetic disease process is likely to be genetically mediated but environmentally initiated and modulated, focused epidemiological studies of genetically characterized populations offer the prospect of environmental intervention with ultimate genotype-specific prevention of the development of diabetes.
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